202 related articles for article (PubMed ID: 17562633)
1. Screening, prevention, detection, and treatment of cancer therapy-induced bone loss in patients with breast cancer.
Limburg CE
Oncol Nurs Forum; 2007 Jan; 34(1):55-63. PubMed ID: 17562633
[TBL] [Abstract][Full Text] [Related]
2. Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer.
Swenson KK; Henly SJ; Shapiro AC; Schroeder LM
Clin J Oncol Nurs; 2005 Apr; 9(2):177-84. PubMed ID: 15853161
[TBL] [Abstract][Full Text] [Related]
3. Bone loss and fracture risk associated with cancer therapy.
Guise TA
Oncologist; 2006; 11(10):1121-31. PubMed ID: 17110632
[TBL] [Abstract][Full Text] [Related]
4. Hormone- and chemotherapy-induced bone loss in breast cancer.
Coleman RE
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):16-20. PubMed ID: 15202583
[TBL] [Abstract][Full Text] [Related]
5. Adverse bone effects during pharmacological breast cancer therapy.
Bjarnason NH; Hitz M; Jorgensen NR; Vestergaard P
Acta Oncol; 2008; 47(4):747-54. PubMed ID: 18465344
[TBL] [Abstract][Full Text] [Related]
6. Aging and osteoporosis in breast and prostate cancer.
VanderWalde A; Hurria A
CA Cancer J Clin; 2011; 61(3):139-56. PubMed ID: 21543824
[TBL] [Abstract][Full Text] [Related]
7. Cancer treatment-induced bone loss.
Adler RA
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):442-5. PubMed ID: 17982349
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis: a concern for cancer survivors.
Mahon SM
Oncol Nurs Forum; 1998 Jun; 25(5):843-51; quiz 852-3. PubMed ID: 9644700
[TBL] [Abstract][Full Text] [Related]
9. The causes and treatment of bone loss associated with carcinoma of the breast.
Lester J; Dodwell D; McCloskey E; Coleman R
Cancer Treat Rev; 2005 Apr; 31(2):115-42. PubMed ID: 15847981
[TBL] [Abstract][Full Text] [Related]
10. Prevention of osteoporosis after breast cancer.
Reid DM
Maturitas; 2009 Sep; 64(1):4-8. PubMed ID: 19709826
[TBL] [Abstract][Full Text] [Related]
11. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
Brufsky AM
Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
[TBL] [Abstract][Full Text] [Related]
12. Cancer treatment-induced bone loss in breast and prostate cancer.
Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
[TBL] [Abstract][Full Text] [Related]
13. Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.
Saarto T; Vehmanen L; Blomqvist C; Elomaa I
J Clin Oncol; 2008 Sep; 26(26):4289-95. PubMed ID: 18779616
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of osteoporosis in nonmetastatic breast cancer].
Eiken PA; Hansen M; Kristensen B; Langdahl BL; Abrahamsen B
Ugeskr Laeger; 2011 Feb; 173(8):577-81. PubMed ID: 21333258
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis.
Camacho PM; Dayal AS; Diaz JL; Nabhan FA; Agarwal M; Norton JG; Robinson PA; Albain KS
J Clin Oncol; 2008 Nov; 26(33):5380-5. PubMed ID: 18955450
[TBL] [Abstract][Full Text] [Related]
16. The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause.
Tham YL; Sexton K; Weiss HL; Elledge RM; Friedman LC; Kramer RM
J Support Oncol; 2006 Jun; 4(6):295-8, 304. PubMed ID: 16805332
[TBL] [Abstract][Full Text] [Related]
17. Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy.
Schwartz AL; Winters-Stone K; Gallucci B
Oncol Nurs Forum; 2007 May; 34(3):627-33. PubMed ID: 17573321
[TBL] [Abstract][Full Text] [Related]
18. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of osteoporosis in women with a history of breast carcinoma.
Van Poznak C; Sauter NP
Cancer; 2005 Aug; 104(3):443-56. PubMed ID: 15968687
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
